Fucoidan as a Potential Therapeutic for Major Blinding Diseases-A Hypothesis

被引:31
|
作者
Klettner, Alexa [1 ]
机构
[1] Univ Kiel, Univ Med Ctr, Dept Ophthalmol, D-24105 Kiel, Germany
来源
MARINE DRUGS | 2016年 / 14卷 / 02期
关键词
fucoidan; age-related macular degeneration; diabetic retinopathy; oxidative stress; VEGF; complement; ENDOTHELIAL GROWTH-FACTOR; MOLECULAR-WEIGHT FUCOIDAN; ACTIVATED PROTEIN-KINASES; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; OXIDATIVE-STRESS; SULFATED POLYSACCHARIDES; INHIBITS ANGIOGENESIS; ASCOPHYLLUM-NODOSUM; TUMOR ANGIOGENESIS;
D O I
10.3390/md14020031
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fucoidan is a heterogeneous group of sulfated polysaccharide with a high content of l-fucose, which can be extracted from brown algae and marine invertebrates. It has many beneficial biological activities that make fucoidan an interesting candidate for therapeutic application in a variety of diseases. Age-related macular degeneration and diabetic retinopathy are major causes for vision loss and blindness in the industrialized countries and increasingly in the developing world. Some of the characteristics found in certain fucoidans, such as its anti-oxidant activity, complement inhibition or interaction with the Vascular Endothelial Growth factor, which would be of high interest for a potential application of fucoidan in age-related macular degeneration or diabetic retinopathy. However, the possible usage of fucoidan in ophthalmological diseases has received little attention so far. In this review, biological activities of fucoidan that could be of interest regarding these diseases will be discussed.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Therapeutic potential of neuromodulation for demyelinating diseases
    ElliotH.Choi
    ChiomaNwakalor
    NolanJ.Brown
    JoonhoLee
    MichaelY.Oh
    InHongYang
    [J]. Neural Regeneration Research, 2021, 16 (02) : 214 - 217
  • [32] Therapeutic potential of rifaximin in liver diseases
    Yang, Wanting
    Guo, Gaoyue
    Sun, Chao
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2024, 178
  • [33] The therapeutic potential of resolvins in pulmonary diseases
    Centanni, Daniel
    Henricks, Paul A. J.
    Engels, Ferdi
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 958
  • [34] Potential therapeutic approaches for prion diseases
    Adjou, KT
    [J]. HUMAN AND ANIMAL PRION DISEASES, 2002, : 103 - 109
  • [35] THERAPEUTIC POTENTIAL OF PACAP FOR NEURODEGENERATIVE DISEASES
    Yang, Rongqiang
    Jiang, Xin
    Ji, Rui
    Meng, Lingbin
    Liu, Fuli
    Chen, Xiaolei
    Xin, Ying
    [J]. CELLULAR & MOLECULAR BIOLOGY LETTERS, 2015, 20 (02) : 265 - 278
  • [36] MicroRNAs in neurodegenerative diseases and their therapeutic potential
    Junn, Eunsung
    Mouradian, M. Maral
    [J]. PHARMACOLOGY & THERAPEUTICS, 2012, 133 (02) : 142 - 150
  • [37] Therapeutic potential of NAD(+) for neurological diseases
    Ying, Weihai
    [J]. FUTURE NEUROLOGY, 2007, 2 (02) : 129 - 132
  • [38] Therapeutic potential of RNAi in metabolic diseases
    Rondinone, CM
    [J]. BIOTECHNIQUES, 2006, 40 (04) : 31 - 36
  • [39] Therapeutic potential of curcumin in digestive diseases
    Dulbecco, Pietro
    Savarino, Vincenzo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (48) : 9256 - 9270
  • [40] The Therapeutic Potential of Epigenetics in Autoimmune Diseases
    Maria De Santis
    Carlo Selmi
    [J]. Clinical Reviews in Allergy & Immunology, 2012, 42 : 92 - 101